NEWARK, Calif., May 8, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO), today reported financial results for the first quarter ended March 31, 2014.
First Quarter 2014 Business Highlights
-- Relaunched migraine product CAMBIA(R) (diclofenac potassium for oral solution) in February 2014
Help employers find you! Check out all the jobs and post your resume.
